StocksFin Logo
Henry Schein, Inc. country of incorporation
|
|
Mr. Stanley Bergman
|
22,000 employees
NASDAQ | Healthcare | Medical Distribution
BioMarin Pharmaceutical Inc. country of incorporation
|
|
Mr. Jean-Jacques Bienaime
|
3,045 employees
NASDAQ | Healthcare | Biotechnology
Q122 reported May 3, 2022 Reporting Period
$3.18B 8.7% vs. Q121 Revenues Q122
30.61% 0.5% vs. Q121 Gross Profit Margin
5.69% 0.3% vs. Q121 Net Profit Margin
74M 16.8% vs. Q121 Free Cash Flow Q122
$1.31 12% vs. Q121 EPS Q122
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q122
Q322
Q322 reported Oct 28, 2022 Reporting Period
$505.34M 23.6% vs. Q321 Revenues Q322
76.99% 3.1% vs. Q321 Gross Profit Margin
-1.32% ! 85.3% vs. Q321 Net Profit Margin
121.85M 25.5% vs. Q321 Free Cash Flow Q322
$-0.04 ! 80% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q122
Q322
Loading...
Loading...
Loading...
Loading...
Ratios
As of
Mar 31, 2022
Sep 30, 2022
Quick Ratio
0.73
3.25
Current Ratio
1.79
5.15
Cash Ratio
0.06
1.46
Price to Book
3.33
3.44
Price to Sales
3.77
31.13
Price to Earnings
16.53
-591.29